anonymous
Guest
anonymous
Guest
Ha ha ha, F your attorneys!!
https://www.reuters.com/legal/gsk-d...g-zantac-litigation-shares-down-4-2023-03-24/
https://www.reuters.com/legal/gsk-d...g-zantac-litigation-shares-down-4-2023-03-24/
When GSK was fined billions a decade ago for a variety of missteps, it had billions already set aside in an account to cover the penalty and to prevent the stock from crashing when fine were given.
This time around with Zantac and cancer, the money is already set aside for when the fines are levied. GSK knowingly marketed a product that causes cancer. They realized that to sell Zantac to patients there is a cost beyond R&D and marketing costs. In the end Glaxo made billions above and beyond whatever the settlement is- just the cost of doing business and harming patients for profits.
Shame on GSK and others like them.
there is no way that statement is correct. There us a cost of doing business, but public trust is one of the biggest factors in order to continue sell medicines and make money
Honestly, it's amazing that our company is still around.
- Low margin high volume product promotion in 3rd world countries. Way to go Andy!
- The largest CIA in pharmaceutical history. Thanks Andy!
- An incentive comp plan where reps are tested but never shown their scores.
- R&D that hasn't produced anything of significance in the last two decades.
- More layoffs than any other major pharma company of the past two decades.
- A CEO whose resume is primarily composed makeup and lipstick. Hires all women leadership team. Deirdre, Mya, Deborah.
- We are the worlds largest vaccine manufacturer and we couldn't capitalize on the COVID pandemic.
- Stock price that has been flat for decades.